{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:32:23Z","timestamp":1793082743453,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:00:00Z","timestamp":1791676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2025307007"],"award-info":[{"award-number":["H2025307007"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejphar.2026.179418","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:45:43Z","timestamp":1791503143000},"page":"179418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tirzepatide alleviates hepatic steatosis and inflammation in MASLD partly through suppression of macrophage Dectin-1\/Syk\/NF-\u03baB signaling"],"prefix":"10.1016","volume":"1037","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2115-8236","authenticated-orcid":false,"given":"Ying","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanfan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1174-908X","authenticated-orcid":false,"given":"Yongning","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179418_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-026-01288-0","article-title":"Kupffer cells in liver homeostasis and disease: from immune sentinels to metabolic gatekeepers","author":"Araujo David","year":"2026","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179418_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179418_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","article-title":"Pattern recognition receptors: function, regulation and therapeutic potential","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179418_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.it.2021.08.005","article-title":"Emerging roles of Dectin-1 in noninfectious settings and in the CNS","volume":"42","author":"Deerhake","year":"2021","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179418_bib5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179418_bib6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCULATIONAHA.118.036044","article-title":"Dectin-1 contributes to myocardial ischemia\/reperfusion injury by regulating macrophage polarization and neutrophil infiltration","volume":"139","author":"Fan","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179418_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179418_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S2213-8587(22)00070-5","article-title":"Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial","volume":"10","author":"Gastaldelli","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179418_bib9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41423-025-01307-5","article-title":"Immunopathogenic mechanisms and immunoregulatory therapies in MASLD","volume":"22","author":"He","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179418_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S2213-8587(22)00085-7","article-title":"Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial","volume":"10","author":"Heise","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179418_bib11","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/hep.31897","article-title":"A systematic review of animal models of NAFLD finds high-fat, high-fructose diets Most closely resemble human NAFLD","volume":"74","author":"Im","year":"2021","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179418_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179418_bib13","article-title":"Inflammation in MASLD progression and cancer","volume":"7","author":"Kim","year":"2025","journal-title":"JHEP Rep."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179418_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179418_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jhepr.2019.02.004","article-title":"Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism","volume":"1","author":"Lefere","year":"2019","journal-title":"JHEP Rep."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179418_bib16","article-title":"Tirzepatide, a dual GIP\/GLP-1 receptor agonist, alleviates metabolic dysfunction-associated steatotic liver disease by reducing the expression of CD36 and OBP2A","volume":"12","author":"Li","year":"2025","journal-title":"Genes Dis."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179418_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179418_bib18","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1038\/s44319-024-00296-2","article-title":"The Dectin-1 and Dectin-2 clusters: C-type lectin receptors with fundamental roles in immunity","volume":"25","author":"Malamud","year":"2024","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179418_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s42255-018-0001-z","article-title":"GIP regulates inflammation and body weight by restraining myeloid-cell-derived S100A8\/A9","volume":"1","author":"Mantelmacher","year":"2019","journal-title":"Nat. Metab."},{"issue":"22","key":"10.1016\/j.ejphar.2026.179418_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153732","article-title":"Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide","volume":"6","author":"McLean","year":"2021","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179418_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.immuni.2011.05.001","article-title":"Myeloid C-type lectin receptors in pathogen recognition and host defense","volume":"34","author":"Osorio","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2026.179418_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101008","article-title":"The gut hormone receptor GIPR links energy availability to the control of hematopoiesis","volume":"39","author":"Pujadas","year":"2020","journal-title":"Mol. Metabol."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179418_bib23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179418_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s44324-025-00083-0","article-title":"Sterile inflammation in MASH: emerging role of extracellular RNA and therapeutic strategies","volume":"3","author":"Raza","year":"2025","journal-title":"NPJ Metab. Health Dis."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179418_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146353","article-title":"GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice","volume":"131","author":"Samms","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.ejphar.2026.179418_bib26","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.cmet.2023.10.009","article-title":"The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease","volume":"35","author":"Sawada","year":"2023","journal-title":"Cell Metab."},{"issue":"24","key":"10.1016\/j.ejphar.2026.179418_bib27","first-page":"2492","article-title":"Tirzepatide for obesity treatment and diabetes prevention","volume":"392","author":"Shukla","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179418_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"18","key":"10.1016\/j.ejphar.2026.179418_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186420","article-title":"MASH: the nexus of metabolism, inflammation, and fibrosis","volume":"135","author":"Steinberg","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179418_bib30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.23337","article-title":"Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity","volume":"51","author":"Stienstra","year":"2010","journal-title":"Hepatology"},{"issue":"42","key":"10.1016\/j.ejphar.2026.179418_bib31","article-title":"Macrophage-hepatocyte circuits mediated by grancalcin aggravate the progression of metabolic dysfunction associated steatohepatitis","volume":"11","author":"Su","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179418_bib32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179418_bib33","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1210\/clinem\/dgaa863","article-title":"Dual GIP and GLP-1 receptor agonist tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes","volume":"106","author":"Thomas","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179418_bib34","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1182\/blood-2005-03-1239","article-title":"Dectin-1 activates syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production","volume":"106","author":"Underhill","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ejphar.2026.179418_bib35","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s42255-024-01043-6","article-title":"An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"6","author":"Vacca","year":"2024","journal-title":"Nat. Metab."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179418_bib36","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jcmgh.2023.03.002","article-title":"The multifaceted roles of macrophages in NAFLD pathogenesis","volume":"15","author":"Vonderlin","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179418_bib37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41401-022-00926-2","article-title":"Dectin-1 plays a deleterious role in high fat diet-induced NAFLD of mice through enhancing macrophage activation","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179418_bib38","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3350\/cmh.2024.0107","article-title":"Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy","volume":"30","author":"Wang","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179418_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"21","key":"10.1016\/j.ejphar.2026.179418_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194751","article-title":"Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits","volume":"135","author":"Wong","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"Suppl","key":"10.1016\/j.ejphar.2026.179418_bib41","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of metabolic dysfunction-associated steatotic liver disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179418_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166911","article-title":"Dectin1 contributes to hypertensive vascular injury by promoting macrophage infiltration through activating the Syk\/NF-\u03baB pathway","volume":"1870","author":"Zhang","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179418_bib42","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/s41467-022-30174-1","article-title":"TH17 cells promote CNS inflammation by sensing danger signals via mincle","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926009003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926009003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:32:50Z","timestamp":1793079170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926009003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":43,"alternative-id":["S0014299926009003"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179418","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tirzepatide alleviates hepatic steatosis and inflammation in MASLD partly through suppression of macrophage Dectin-1\/Syk\/NF-\u03baB signaling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179418","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"179418"}}